Skip to main content
Top
Published in: International Urology and Nephrology 2/2009

01-06-2009 | Nephrology - Review

Magnesium metabolism in health and disease

Author: Carlos G. Musso

Published in: International Urology and Nephrology | Issue 2/2009

Login to get access

Abstract

Magnesium (Mg) is the main intracellular divalent cation, and under basal conditions the small intestine absorbs 30–50% of its intake. Normal serum Mg ranges between 1.7–2.3 mg/dl (0.75–0.95 mmol/l), at any age. Even though eighty percent of serum Mg is filtered at the glomerulus, only 3% of it is finally excreted in the urine. Altered magnesium balance can be found in diabetes mellitus, chronic renal failure, nephrolithiasis, osteoporosis, aplastic osteopathy, and heart and vascular disease. Three physiopathologic mechanisms can induce Mg deficiency: reduced intestinal absorption, increased urinary losses, or intracellular shift of this cation. Intravenous or oral Mg repletion is the main treatment, and potassium-sparing diuretics may also induce renal Mg saving. Because the kidney has a very large capacity for Mg excretion, hypermagnesemia usually occurs in the setting of renal insufficiency and excessive Mg intake. Body excretion of Mg can be enhanced by use of saline diuresis, furosemide, or dialysis depending on the clinical situation.
Literature
1.
go back to reference Belorin Font E (2007) Magnesio. In: Ayus C, Caramelo C, Tejedor A (eds) Agua, electrolitos y equilibrio ácido-base. Panamericana, Buenos Aires, pp 293–294 Belorin Font E (2007) Magnesio. In: Ayus C, Caramelo C, Tejedor A (eds) Agua, electrolitos y equilibrio ácido-base. Panamericana, Buenos Aires, pp 293–294
2.
go back to reference Belorin Font E (2007) Hipomagnesemia e hipermagnesemia. In: Ayus C, Caramelo C, Tejedor A (eds) Agua, electrolitos y equilibrio ácido-base. Panamericana, Buenos Aires, pp 341–344 Belorin Font E (2007) Hipomagnesemia e hipermagnesemia. In: Ayus C, Caramelo C, Tejedor A (eds) Agua, electrolitos y equilibrio ácido-base. Panamericana, Buenos Aires, pp 341–344
3.
go back to reference Kelepouris E, Agus Z (1998) Hypomagnesemia: renal magnesium handling. Semin nephrol 18:58–73PubMed Kelepouris E, Agus Z (1998) Hypomagnesemia: renal magnesium handling. Semin nephrol 18:58–73PubMed
4.
go back to reference Rude R, Gruber H, Wei L, Frausto A, Mills B (2003) Magnesium deficiency: effect on bone and mineral metabolism in the mouse. Calcif Tissue Int. 72:32–41PubMedCrossRef Rude R, Gruber H, Wei L, Frausto A, Mills B (2003) Magnesium deficiency: effect on bone and mineral metabolism in the mouse. Calcif Tissue Int. 72:32–41PubMedCrossRef
5.
go back to reference Graham LA, Caesar JJ, Burgen ASV (1960) Gastrointestinal absorption and excretion of magnesium in man. Metabolism 9:646–659 Graham LA, Caesar JJ, Burgen ASV (1960) Gastrointestinal absorption and excretion of magnesium in man. Metabolism 9:646–659
6.
go back to reference Rude R (1996) Magnesium disorders. In: Kokko J, Tannen R (eds) Fluids and electrolytes. Saunders Company, W.B. Philadelphia, pp 421–445 Rude R (1996) Magnesium disorders. In: Kokko J, Tannen R (eds) Fluids and electrolytes. Saunders Company, W.B. Philadelphia, pp 421–445
7.
go back to reference Spiegel D (2007) The role of magnesium binders in chronic kidney disease. Semin dial 20(4):333–336PubMedCrossRef Spiegel D (2007) The role of magnesium binders in chronic kidney disease. Semin dial 20(4):333–336PubMedCrossRef
8.
go back to reference Yu A (2004) Renal transport of calcium, magnesium and phosphate. In: Brenner B (ed) Brenner & Rector’s The kidney. Saunders, Philadelphia, pp 535–571 Yu A (2004) Renal transport of calcium, magnesium and phosphate. In: Brenner B (ed) Brenner & Rector’s The kidney. Saunders, Philadelphia, pp 535–571
9.
go back to reference Kaplan N, Palmer B, Sakhaee K, Gonzalez G (1999) Update on renal osteodystrophy: pathogenesis and clinical management. Am J Med Sci 317(4):251–260CrossRef Kaplan N, Palmer B, Sakhaee K, Gonzalez G (1999) Update on renal osteodystrophy: pathogenesis and clinical management. Am J Med Sci 317(4):251–260CrossRef
10.
go back to reference Guyton A, Hall J (2002) Manual de Fisiología Médica. McGraw–Hill, Interamericana, Madrid Guyton A, Hall J (2002) Manual de Fisiología Médica. McGraw–Hill, Interamericana, Madrid
11.
go back to reference Wen SF, Evanson RL, Dirks JH (1970) Micropuncture study of renal magnesium transport in proximal and distal tubule of dog. Am J Physiol 219:570–576PubMed Wen SF, Evanson RL, Dirks JH (1970) Micropuncture study of renal magnesium transport in proximal and distal tubule of dog. Am J Physiol 219:570–576PubMed
12.
go back to reference Brunette MG, Vigneault N, Carriere S (1974) Micropuncture study of magnesium transport along the nephron in the young rat. Am J Physiol 227:891–896PubMed Brunette MG, Vigneault N, Carriere S (1974) Micropuncture study of magnesium transport along the nephron in the young rat. Am J Physiol 227:891–896PubMed
13.
go back to reference Shareghi GR, Agus ZS (1982) Magnesium transport in the cortical thick ascending limb of Henle’s loop of the rabbit. J Clin invest 69:759–769PubMedCrossRef Shareghi GR, Agus ZS (1982) Magnesium transport in the cortical thick ascending limb of Henle’s loop of the rabbit. J Clin invest 69:759–769PubMedCrossRef
14.
go back to reference Riccardi D, Hall AE, Chattopadhyay N et al (1998) Localization of the extracellular calcium sensing protein in the rat kidney. Am J Physiol 274:F611–F622PubMed Riccardi D, Hall AE, Chattopadhyay N et al (1998) Localization of the extracellular calcium sensing protein in the rat kidney. Am J Physiol 274:F611–F622PubMed
15.
go back to reference Macías Núñez JF, Cameron S (2006) Renal function in the elderly. In: Cameron S (ed) Oxford textbook of clinical nephrology. Oxford University Press, Oxford Macías Núñez JF, Cameron S (2006) Renal function in the elderly. In: Cameron S (ed) Oxford textbook of clinical nephrology. Oxford University Press, Oxford
16.
go back to reference Musso CG, Macías Núñez JF (2008) Renal acidification, calcium, phosphate and magnesium. In: Macías Núñez JF, Cameron S, Oreopoulos D (eds) Renal ageing: health and disease. Springer, New York, pp 155–171CrossRef Musso CG, Macías Núñez JF (2008) Renal acidification, calcium, phosphate and magnesium. In: Macías Núñez JF, Cameron S, Oreopoulos D (eds) Renal ageing: health and disease. Springer, New York, pp 155–171CrossRef
17.
go back to reference Quamme GA (1982) Effect of hypercalcemia on renal tubular handling of calcium and magnesium. Can J Physiol Pharmacol 60:1275–1280PubMed Quamme GA (1982) Effect of hypercalcemia on renal tubular handling of calcium and magnesium. Can J Physiol Pharmacol 60:1275–1280PubMed
18.
go back to reference Millane TA, Ward DE, Camm AJ (1992) Electrophysiology, pacing and arrhythmia. Clin Cardiol 15:103–108PubMedCrossRef Millane TA, Ward DE, Camm AJ (1992) Electrophysiology, pacing and arrhythmia. Clin Cardiol 15:103–108PubMedCrossRef
20.
go back to reference Braden GL, Germain MJ, Fitzgibbons JP (1985) Impaired potassium and magnesium homeostasis in acute tubulo-interstitial nephritis. Nephron 41:273–278PubMedCrossRef Braden GL, Germain MJ, Fitzgibbons JP (1985) Impaired potassium and magnesium homeostasis in acute tubulo-interstitial nephritis. Nephron 41:273–278PubMedCrossRef
21.
go back to reference Mason J (1990) Renal side-effects of cyclosporine. Transplant proc 22:1280–1283PubMed Mason J (1990) Renal side-effects of cyclosporine. Transplant proc 22:1280–1283PubMed
22.
go back to reference Rude RK (1993) Magnesium metabolism and deficiency. Endocrinol Metab Clin North Am 22:377–395PubMed Rude RK (1993) Magnesium metabolism and deficiency. Endocrinol Metab Clin North Am 22:377–395PubMed
23.
go back to reference Eisenbud E, LoBue CC (1976) Hypocalcemia after therapeutic use of magnesium sulphate. Arch Intern Med 136:688–691PubMedCrossRef Eisenbud E, LoBue CC (1976) Hypocalcemia after therapeutic use of magnesium sulphate. Arch Intern Med 136:688–691PubMedCrossRef
24.
go back to reference Navarro J, Oster JR, Gknosos PJ et al (1991) Tetany induced on separate occasions by administration of potassium and magnesium in a patient with hungry-bone syndrome. Miner Electrolyte Metab 17:340–344PubMed Navarro J, Oster JR, Gknosos PJ et al (1991) Tetany induced on separate occasions by administration of potassium and magnesium in a patient with hungry-bone syndrome. Miner Electrolyte Metab 17:340–344PubMed
25.
go back to reference Bundy JT, Connito D, Mahoney MD et al (1995) Treatment of idiopathic renal magnesium wasting with amiloride. Am J Nephrol 15:75–77PubMedCrossRef Bundy JT, Connito D, Mahoney MD et al (1995) Treatment of idiopathic renal magnesium wasting with amiloride. Am J Nephrol 15:75–77PubMedCrossRef
26.
go back to reference Devane J, Ryan MP (1981) The effects of amiloride and triamterene on urinary magnesium excretion in conscious saline-loaded rats. Br J Pharmacol 72:285–289PubMed Devane J, Ryan MP (1981) The effects of amiloride and triamterene on urinary magnesium excretion in conscious saline-loaded rats. Br J Pharmacol 72:285–289PubMed
27.
go back to reference Christiansen C, Baastrup PC, Transbol L (1976) Lithium, hypercalcemia, hypermagnesemia, and hyperparathyroidism (letter). Lancet 2:969PubMedCrossRef Christiansen C, Baastrup PC, Transbol L (1976) Lithium, hypercalcemia, hypermagnesemia, and hyperparathyroidism (letter). Lancet 2:969PubMedCrossRef
28.
go back to reference Alfrey A (1996) Disorders of magnesium metabolism. In: Bennett JC, Plum F (eds) Cecil textbook of medicine. WB Saunders Company, Philadelphia, pp 1137–1138 Alfrey A (1996) Disorders of magnesium metabolism. In: Bennett JC, Plum F (eds) Cecil textbook of medicine. WB Saunders Company, Philadelphia, pp 1137–1138
29.
go back to reference Atabek M, Kurtoglu S, Pirgon O (2006) Possible effect of leptin on renal magnesium excretion in adolescent patients with type 1 diabetes. Pediatrics Int 48:393–397CrossRef Atabek M, Kurtoglu S, Pirgon O (2006) Possible effect of leptin on renal magnesium excretion in adolescent patients with type 1 diabetes. Pediatrics Int 48:393–397CrossRef
30.
go back to reference Delfini E, Petramala L, Caliumi C, Cotesta D, De Toma G, Cavallaro G, Panzironi G, Diacinti D, Mimisola S, DÉrasmo E, Mazzuoli G, Letizia C (2007) Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metab Clin Exp 56:30–36PubMed Delfini E, Petramala L, Caliumi C, Cotesta D, De Toma G, Cavallaro G, Panzironi G, Diacinti D, Mimisola S, DÉrasmo E, Mazzuoli G, Letizia C (2007) Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metab Clin Exp 56:30–36PubMed
31.
go back to reference Massey L (2005) Magnesium therapy for nephrolithiasis. Magnes Res 18(2):123–126PubMed Massey L (2005) Magnesium therapy for nephrolithiasis. Magnes Res 18(2):123–126PubMed
32.
go back to reference Rude R, Gruber H, Norton J, Wei L, Frausto A, Kilbum J (2005) Dietary magnesium reduction to 25% of nutrient requirement disrupts boné and mineral metabolism in the rat. Bone 37:211–219PubMedCrossRef Rude R, Gruber H, Norton J, Wei L, Frausto A, Kilbum J (2005) Dietary magnesium reduction to 25% of nutrient requirement disrupts boné and mineral metabolism in the rat. Bone 37:211–219PubMedCrossRef
33.
go back to reference D’Hase P, Couttenye M, Lamberts L, Elseviers M, Goodman W, Schrooten I, Cabrera W, De Broe M (1999) Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 45(9):1548–1556 D’Hase P, Couttenye M, Lamberts L, Elseviers M, Goodman W, Schrooten I, Cabrera W, De Broe M (1999) Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 45(9):1548–1556
34.
go back to reference Ng A, Hercz G, Kandel R, Grynpas M (2004) Association between fluoride, magnesium, aluminium and bone quality in renal osteodystrophy. Bone 34:216–224PubMedCrossRef Ng A, Hercz G, Kandel R, Grynpas M (2004) Association between fluoride, magnesium, aluminium and bone quality in renal osteodystrophy. Bone 34:216–224PubMedCrossRef
35.
go back to reference Ersoy F (2007) Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol 39:321–331PubMedCrossRef Ersoy F (2007) Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol 39:321–331PubMedCrossRef
36.
go back to reference Port F, Young E (1996) Fluids and electrolyte disorders in dialysis. In: Kokko J, Tannen R (eds) Fluids and electrolytes. Saunders Company, Philadelphia, pp 533–560 Port F, Young E (1996) Fluids and electrolyte disorders in dialysis. In: Kokko J, Tannen R (eds) Fluids and electrolytes. Saunders Company, Philadelphia, pp 533–560
37.
go back to reference Feriani M, Catizone L, Fracasso A (2000) Peritoneal dialysis solutions and systems. In: Gokal R, Khanna R, Krediet R, Nolph K (eds) Textbook of peritoneal dialysis. Kluwer Academic Publishers, Dordrecht, pp 253–305 Feriani M, Catizone L, Fracasso A (2000) Peritoneal dialysis solutions and systems. In: Gokal R, Khanna R, Krediet R, Nolph K (eds) Textbook of peritoneal dialysis. Kluwer Academic Publishers, Dordrecht, pp 253–305
38.
go back to reference Navarro J, Mora C, Jiménez A, Ci B, Torres A, Macías M, García J (1999) Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis 34(1):43–48PubMedCrossRef Navarro J, Mora C, Jiménez A, Ci B, Torres A, Macías M, García J (1999) Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis 34(1):43–48PubMedCrossRef
39.
go back to reference Alon I, Gorelik O, Berman S, Almoznino-Sarafian D, Shteinshnaider M, Weissgarten J, Modai D, Cohen N (2006) Intracellular magnesium in elderly patients with heart failure: effects of diabetes and renal dysfunction. J Trace Elem Med Biol 20:221–226PubMedCrossRef Alon I, Gorelik O, Berman S, Almoznino-Sarafian D, Shteinshnaider M, Weissgarten J, Modai D, Cohen N (2006) Intracellular magnesium in elderly patients with heart failure: effects of diabetes and renal dysfunction. J Trace Elem Med Biol 20:221–226PubMedCrossRef
40.
go back to reference García-Casasola G, Sánchez-Hernández C, Luengo Pierrad P, Arenas González S, Bilbao Garay J, Zapatero Gaviria A (2004) Hipomagnesemia e insuficiencia cardíaca. Rev Clin Esp 1:43–47 García-Casasola G, Sánchez-Hernández C, Luengo Pierrad P, Arenas González S, Bilbao Garay J, Zapatero Gaviria A (2004) Hipomagnesemia e insuficiencia cardíaca. Rev Clin Esp 1:43–47
41.
go back to reference Ceremuzynski L, Gebalska J, Wolk R, Makowska E (2000) Hipomagnesemia in Herat failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. J Int Med 247:78–86CrossRef Ceremuzynski L, Gebalska J, Wolk R, Makowska E (2000) Hipomagnesemia in Herat failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. J Int Med 247:78–86CrossRef
Metadata
Title
Magnesium metabolism in health and disease
Author
Carlos G. Musso
Publication date
01-06-2009
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2009
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9548-7

Other articles of this Issue 2/2009

International Urology and Nephrology 2/2009 Go to the issue